The Connectivity Map: a new tool for biomedical research
The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
The ultimate objective of biomedical research is to connect human diseases with the genes that underlie them and drugs that treat them. But this remains a daunting task, and even the most inspired researchers still have to resort to laborious screens of genetic or chemical libraries. What if at least some parts of this screening process could be systematized and centralized? And hits found and hypotheses generated with something resembling an internet search engine? These are the questions the Connectivity Map project set out to answer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, they do not support complex molecular readouts such as transcriptome profiling, which is one of the most comprehensive and informative measures of cellular response 5 .”
From Pooled CRISPR screening with single-cell transcriptome readout. (2017) · cites this paper as [5]
In the citing paper
“This tool allowed researchers to investigate genome-wide effects of GHK and establish that GHK-Cu is able to up- and down-regulate a significant number of human genes.”
From Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data (2018) · cites this paper as [3]
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456
Goodman and Gilman's the Pharmacological Basis of Therapeutics
Stigelman, W. H., & Pharm, D. (1986) · Military Medicine · doi:10.1093/milmed/151.1.386 · Cited by 6,782
Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257
Self-citationDruker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J. M., Lydon, N. B., Kantarjian, H., Capdeville, R., Ohno-Jones, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441401 · Cited by 5,243 · cited 1×
“) to rationality (chronic myeloid leukaemia–BCR-ABL–imatini”
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform
Rhodes, D. R., Yu, J., Shanker, K., Deshpande, N., Varambally, R., Ghosh, D., Barrette, T., Pander, A., & Chinnaiyan, A. M. (2004) · Neoplasia · doi:10.1016/s1476-5586(04)80047-2 · Cited by 3,612
A gene atlas of the mouse and human protein-encoding transcriptomes
Su, A. I., Wiltshire, T., Batalov, S., Lapp, H., Ching, K. A., Block, D., Zhang, J., Soden, R., Hayakawa, M., Kreiman, G., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400782101 · Cited by 3,475
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305 · cited 1×
“to individually ablate each of the 600 of the approximately 3,000 human proteins that are predicted to bind drug-like small molecule”
BackgroundTowards a proteome-scale map of the human protein–protein interaction network
Rual, J.-F., Venkatesan, K., Hao, T., Hirozane-Kishikawa, T., Dricot, A., Li, N., Berriz, G. F., Gibbons, F. D., Dreze, M., Ayivi-Guedehoussou, N., et al. (2005) · Nature · doi:10.1038/nature04209 · Cited by 2,933 · cited 1×
“A comprehensive network view of disease processes might ultimately enable the nodes, which when coordinately targeted will effect the desired outcome, to be predicted in silico”
BackgroundFunctional Discovery via a Compendium of Expression Profiles
Hughes, T. R., Marton, M. J., Jones, A. R., Roberts, C. J., Stoughton, R., Armour, C. D., Bennett, H. A., Coffey, E., Dai, H., He, Y. D., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00015-5 · Cited by 2,533 · cited 1×
“The general notion that a compendium of gene-expression profiles could be used for discovery was first proven by Hughes et al”
MethodExpression profiling reveals off-target gene regulation by RNAi
Jackson, A. L., Bartz, S. R., Schelter, J., Kobayashi, S. V., Burchard, J., Mao, M., Li, B., Cavet, G., & Linsley, P. S. (2003) · Nature Biotechnology · doi:10.1038/nbt831 · Cited by 2,370
The development of androgen-independent prostate cancer.
Feldman, B. J., & Feldman, D. (2001) · Nature reviews. Cancer · doi:10.1038/35094009 · Cited by 2,326 · cited 1×
“Motivated by the importance of AR signalling in prostate cancer, and specifically, the paucity of effective therapeutic approaches to hormone-refractory diseas”
BackgroundKinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor
Heinrich, M. C., Corless, C. L., Demetri, G. D., Blanke, C. D., von Mehren, M., Joensuu, H., McGreevey, L. S., Chen, C.-J., Van den Abbeele, A. D., Druker, B. J., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.190 · Cited by 2,299
Reich, M., Liefeld, T., Gould, J., Lerner, J., Tamayo, P., & Mesirov, J. P. (2006) · Nature Genetics · doi:10.1038/ng0506-500 · Cited by 2,032
Multiclass cancer diagnosis using tumor gene expression signatures
Ramaswamy, S., Tamayo, P., Rifkin, R., Mukherjee, S., Yeang, C.-H., Angelo, M., Ladd, C., Reich, M., Latulippe, E., Mesirov, J. P., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211566398 · Cited by 2,023
β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression
Rothstein, J. D., Patel, S., Regan, M. R., Haenggeli, C., Huang, Y. H., Bergles, D. E., Jin, L., Dykes Hoberg, M., Vidensky, S., Chung, D. S., et al. (2005) · Nature · doi:10.1038/nature03180 · Cited by 1,518
Genetics of gene expression surveyed in maize, mouse and man
Schadt, E. E., Monks, S. A., Drake, T. A., Lusis, A. J., Che, N., Colinayo, V., Ruff, T. G., Milligan, S. B., Lamb, J. R., Cavet, G., et al. (2003) · Nature · doi:10.1038/nature01434 · Cited by 1,503
Self-citationLarge-scale analysis of the human and mouse transcriptomes
Su, A. I., Cooke, M. P., Ching, K. A., Hakak, Y., Walker, J. R., Wiltshire, T., Orth, A. P., Vega, R. G., Sapinoso, L. M., Moqrich, A., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012025199 · Cited by 1,466
Activation of the interferon system by short-interfering RNAs
Sledz, C. A., Holko, M., de Veer, M. J., Silverman, R. H., & Williams, B. R. G. (2003) · Nature Cell Biology · doi:10.1038/ncb1038 · Cited by 1,400
The mechanism of action of aspirin
Vane, J. R., & Botting, R. M. (2003) · Thrombosis Research · doi:10.1016/s0049-3848(03)00379-7 · Cited by 1,225
Goodman and Gilman's The Pharmacological Basis of Therapeutics
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-2-175_2 · Cited by 1,224
NCBI GEO: mining millions of expression profiles--database and tools
Barrett, T. (2004) · Nucleic Acids Research · doi:10.1093/nar/gki022 · Cited by 1,206
Roth, B. L., Sheffler, D. J., & Kroeze, W. K. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1346 · Cited by 1,155 · cited 1×
“For example, clozapine — arguably the most successful antipsychotic drug of all time — has high affinity for more than a dozen biogenic amine receptors, and the therapeutic relevance of this target promiscuity is shown by the failure of the agents developed to ligate only a subset of these proteins to deliver substant…”
BackgroundLehmann, J. M., Lenhard, J. M., Oliver, B. B., Ringold, G. M., & Kliewer, S. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3406 · Cited by 1,110
ArrayExpress--a public repository for microarray gene expression data at the EBI
Parkinson, H. (2004) · Nucleic Acids Research · doi:10.1093/nar/gki056 · Cited by 1,075
Boolell, M., Mj, A., Sa, B., Gepi-Attee, S., Muirhead, G. J., Naylor, A. M., Ih, O., & Gingell, C. (1996) · PubMed · Cited by 1,067
An integrative genomics approach to infer causal associations between gene expression and disease
Schadt, E. E., Lamb, J., Yang, X., Zhu, J., Edwards, S., GuhaThakurta, D., Sieberts, S. K., Monks, S., Reitman, M., Zhang, C., et al. (2005) · Nature Genetics · doi:10.1038/ng1589 · Cited by 1,043
Self-citationNavigating chemical space for biology and medicine
Lipinski, C., & Hopkins, A. (2004) · Nature · doi:10.1038/nature03193 · Cited by 1,002 · cited 1×
“However, it is probably impossible, and certainly impractical, to find a small molecule to modulate every protein encoded in the human genom”
BackgroundInduction of an interferon response by RNAi vectors in mammalian cells
Bridge, A. J., Pebernard, S., Ducraux, A., Nicoulaz, A.-L., & Iggo, R. (2003) · Nature Genetics · doi:10.1038/ng1173 · Cited by 961
Aromatase Inhibitors in Breast Cancer
Smith, I. E., & Dowsett, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023246 · Cited by 905 · cited 1×
“Although they ultimately affect breast epithelial cells, they do so by blocking oestrogen synthesis in the strom”
BackgroundGlobal mapping of pharmacological space
Paolini, G. V., Shapland, R. H. B., van Hoorn, W. P., Mason, J. S., & Hopkins, A. L. (2006) · Nature Biotechnology · doi:10.1038/nbt1228 · Cited by 811 · cited 1×
“Indeed, a recent global analysis of conventional screening data for nearly five million nonredundant structures collected over 25 years in both industry and academia found that the total number of human proteins for which chemical tools have been discovered so far is just 836 (Ref”
BackgroundArrayExpress--a public repository for microarray gene expression data at the EBI
Brazma, A. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg091 · Cited by 774
Multicomponent therapeutics for networked systems
Keith, C. T., Borisy, A. A., & Stockwell, B. R. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1609 · Cited by 769
Hieronymus, H., Lamb, J., Ross, K. N., Peng, X. P., Clement, C., Rodina, A., Nieto, M., Du, J., Stegmaier, K., Raj, S. M., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.09.005 · Cited by 624
Self-citationSystematic discovery of multicomponent therapeutics
Borisy, A. A., Elliott, P. J., Hurst, N. W., Lee, M. S., Lehár, J., Price, E. R., Serbedzija, G., Zimmermann, G. R., Foley, M. A., Stockwell, B. R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1337088100 · Cited by 620
Wei, G., Twomey, D., Lamb, J., Schlis, K., Agarwal, J., Stam, R. W., Opferman, J. T., Sallan, S. E., den Boer, M. L., Pieters, R., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.09.006 · Cited by 509
Self-citationCan we rationally design promiscuous drugs?
HOPKINS, A., MASON, J., & OVERINGTON, J. (2006) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2006.01.013 · Cited by 469 · cited 1×
“, and structural biology and chemoinformatics might combine for the rational design of the corresponding selectively promiscuous small-molecule modulator”
BackgroundVidal, M., Brachmann, R. K., Fattaey, A., Harlow, E., & Boeke, J. D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.19.10315 · Cited by 427 · cited 1×
“Reconstitution with disease-associated, constitutively-active or interaction-defective (such as mutant proteins capable of physical interaction with only a subset of their usual binding partners”
BackgroundA Mechanism of Cyclin D1 Action Encoded in the Patterns of Gene Expression in Human Cancer
Lamb, J., Ramaswamy, S., Ford, H. L., Contreras, B., Martinez, R. V., Kittrell, F. S., Zahnow, C. A., Patterson, N., Golub, T. R., & Ewen, M. E. (2003) · Cell · doi:10.1016/s0092-8674(03)00570-1 · Cited by 416
Self-citationGenome-scale loss-of-function screening with a lentiviral RNAi library
Root, D. E., Hacohen, N., Hahn, W. C., Lander, E. S., & Sabatini, D. M. (2006) · Nature Methods · doi:10.1038/nmeth924 · Cited by 357
Lindsay, M. A. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1202 · Cited by 332
Frantz, S. (2005) · Nature · doi:10.1038/437942a · Cited by 322 · cited 1×
“But however one chooses to look at it, the exploitation of promiscuity is an emerging theme for drug discover”
BackgroundGanter, B., Tugendreich, S., Pearson, C. I., Ayanoglu, E., Baumhueter, S., Bostian, K. A., Brady, L., Browne, L. J., Calvin, J. T., Day, G.-J., et al. (2005) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2005.03.022 · Cited by 285
Gene expression–based high-throughput screening(GE-HTS) and application to leukemia differentiation
Stegmaier, K., Ross, K. N., Colavito, S. A., O'Malley, S., Stockwell, B. R., & Golub, T. R. (2004) · Nature Genetics · doi:10.1038/ng1305 · Cited by 268
From Knowing to Controlling: A Path from Genomics to Drugs Using Small Molecule Probes
Strausberg, R. L., & Schreiber, S. L. (2003) · Science · doi:10.1126/science.1083395 · Cited by 260
Human ORFeome Version 1.1: A Platform for Reverse Proteomics
Rual, J.-F., Hirozane-Kishikawa, T., Hao, T., Bertin, N., Li, S., Dricot, A., Li, N., Rosenberg, J., Lamesch, P., Vidalain, P.-O., et al. (2004) · Genome Research · doi:10.1101/gr.2973604 · Cited by 241 · cited 1×
“We will, therefore, exploit genome-wide open-reading frame (ORF”
Mehrabian, M., Allayee, H., Stockton, J., Lum, P. Y., Drake, T. A., Castellani, L. W., Suh, M., Armour, C., Edwards, S., Lamb, J., et al. (2005) · Nature Genetics · doi:10.1038/ng1619 · Cited by 221
Self-citationA method for high-throughput gene expression signature analysis
Peck, D., Crawford, E. D., Ross, K. N., Stegmaier, K., Golub, T. R., & Lamb, J. (2006) · Genome Biology · doi:10.1186/gb-2006-7-7-r61 · Cited by 206
Self-citationSildenafil (Viagra) and Ophthalmology
Marmor, M. F., & Kessler, R. (1999) · Survey of Ophthalmology · doi:10.1016/s0039-6257(99)00079-x · Cited by 172
Reiss, T. F., Altman, L. C., Chervinsky, P., Bewtra, A., Stricker, W. E., Noonana, G. P., Kundu, S., & Zhang, J. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)70086-6 · Cited by 160
Gefitinib induces myeloid differentiation of acute myeloid leukemia
Stegmaier, K., Corsello, S. M., Ross, K. N., Wong, J. S., DeAngelo, D. J., & Golub, T. R. (2005) · Blood · doi:10.1182/blood-2005-02-0488 · Cited by 132
Classification of a large microarray data set: Algorithm comparison and analysis of drug signaturesPreprint
Natsoulis, G., Ghaoui, L. E., Lanckriet, G. R. G., Tolley, A. M., Leroy, F., Dunlea, S., Eynon, B. P., Pearson, C. I., Tugendreich, S., & Jarnagin, K. (2005) · Genome Research · doi:10.1101/gr.2807605 · Cited by 122
Clinically Approved Heterocyclics Act on a Mitochondrial Target and Reduce Stroke-induced Pathology
Stavrovskaya, I. G., Narayanan, M. V., Zhang, W., Krasnikov, B. F., Heemskerk, J., Young, S. S., Blass, J. P., Brown, A. M., Beal, M. F., Friedlander, R. M., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20032053 · Cited by 100
Drugs from Emasculated Hormones: The Principle of Syntopic Antagonism
Black, J. W. (1989) · Science · doi:10.1126/science.2569237 · Cited by 95
Small Molecules, Big Players: the National Cancer Institute's Initiative for Chemical Genetics
Tolliday, N. J., Clemons, P. A., Ferraiolo, P., Koehler, A. N., Lewis, T. A., Li, X., Schreiber, S. L., Gerhard, D. S., & Eliasof, S. D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2552 · Cited by 71
Sildenafil (Viagra) and Ophthalmology
Marmor, M. F. (1999) · Archives of Ophthalmology · doi:10.1001/archopht.117.4.518 · Cited by 62
The promise of genomics to identify novel therapeutic targets
Orth, A. P., Batalov, S., Perrone, M. H., & Chanda, S. K. (2004) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.8.6.587 · Cited by 56 · cited 1×
“to individually ablate each of the 600 of the approximately 3,000 human proteins that are predicted to bind drug-like small molecule”
BackgroundAlzheimer’s disease drug discovery targeted to the APP mRNA 5′Untranslated region
Rogers, J. T., Randall, J., Eder, P. S., Huang, X., Bush, A. I., Tanzi, R. E., Venti, A., Payton, S. M., Giordano, T., Nagano, S., et al. (2002) · Journal of Molecular Neuroscience · doi:10.1007/s12031-002-0014-6 · Cited by 56 · cited 1×
“This, taken together with the high frequency with which these agents are shown to have additional desirable activities (see for example Ref”
BackgroundTreating Neurodegenerative Diseases with Antibiotics
Miller, T. M., & Cleveland, D. W. (2005) · Science · doi:10.1126/science.1109027 · Cited by 52
Profiling of hepatic gene expression in rats treated with fibric acid analogs
Cornwell, P. D., Souza, A. T. D., & Ulrich, R. G. (2004) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2003.12.019 · Cited by 46 · cited 1×
“As expected, being off by one log of concentration turned a strong signal into a barely detectable one, as had been shown befor”
Background[Unilateral exophthalmos secondary to orbital metastasis as initial manifestation of breast cancer].
Porcel, J. M., Salud, A., & Balil, A. (2002) · PubMed · Cited by 45
The completed human genome: implications for chemical biology
Austin, C. P. (2003) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(03)00083-8 · Cited by 35 · cited 1×
“An increasing appreciation of chemical genetics and the resulting desire to find bioactive 'tool' compounds to probe and annotate biologies of interes”
BackgroundMilstein, S., & Vidal, M. (2005) · Nature Methods · doi:10.1038/nmeth0605-412 · Cited by 5
Cited by
Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery
Thomford, N. E., Senthebane, D. A., Rowe, A., Munro, D., Seele, P., Maroyi, A., & Dzobo, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061578 · Cited by 1,241
Pooled CRISPR screening with single-cell transcriptome readout.
Datlinger, P., Rendeiro, A. F., Schmidl, C., Krausgruber, T., Traxler, P., Klughammer, J., Schuster, L. C., Kuchler, A., Alpar, D., & Bock, C. (2017) · Nature Methods · doi:10.1038/nmeth.4177 · Cited by 1,096
ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments
Lachmann, A., Xu, H., Krishnan, J., Berger, S. I., Mazloom, A. R., & Ma'ayan, A. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq466 · Cited by 1,029
Survivin, cancer networks and pathway-directed drug discovery
Altieri, D. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2293 · Cited by 994
PREDICT: a method for inferring novel drug indications with application to personalized medicine
Gottlieb, A., Stein, G. Y., Ruppin, E., & Sharan, R. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.26 · Cited by 881
Metadata
- Authors
- Lamb, J.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Lamb, Justin
- Venue
- Nature Reviews Cancer
- Published
- 2007-01
- Volume
- 7
- Issue
- 1
- Pages
- 54-60
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2029980980
- Semantic Scholar
- d1610ee5045d33be16a9a72a514fea537ba46306
- Cited by
- 945
- References
- 66
- Citations by year
- 2026: 11 · 2025: 29 · 2024: 75 · 2023: 54 · 2022: 56 · 2021: 100 · 2020: 79 · 2019: 64 · 2018: 60 · 2017: 52 · 2016: 58 · 2015: 57 · 2014: 42 · 2013: 49 · 2012: 56
- FWCI
- 1.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Broad Institute
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Keywords
- Connectivity Map, gene-disease association, drug repurposing, gene expression profiling, cancer research, drug discovery
- MeSH terms
- Algorithms, Animals, Gene Expression Regulation, Humans, Information Services, Models, Biological, Models, Genetic, Neoplasms, Phenotype, Software, Information Storage and Retrieval, Genome, Computational Biology, Biomedical Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.